FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2085594260> ?p ?o ?g. }

• W2085594260 endingPage "750" @default.
• W2085594260 startingPage "737" @default.
• W2085594260 abstract "Abstract Background: The β-lactam antibiotic ceftriaxone stimulates glutamate transporter GLT-1 expression and is effective in neuropathic and visceral pain models. This study examined the effects of ceftriaxone and its interactions with different analgesics (ibuprofen, celecoxib, paracetamol, and levetiracetam) in somatic and visceral pain models in rodents. Methods: The effects of ceftriaxone (intraperitoneally/intraplantarly), analgesics (orally), and their combinations were examined in the carrageenan-induced paw inflammatory hyperalgesia model in rats (n = 6–12) and in the acetic acid-induced writhing test in mice (n = 6–10). The type of interaction between ceftriaxone and analgesics was determined by isobolographic analysis. Results: Pretreatment with intraperitoneally administered ceftriaxone (10–200 mg/kg per day) for 7 days produced a significant dose-dependent antihyperalgesia in the somatic inflammatory model. Acute administration of ceftriaxone, via either intraperitoneal (10–200 mg/kg) or intraplantar (0.05–0.2 mg per paw) routes, produced a significant and dose-dependent but less efficacious antihyperalgesia. In the visceral pain model, significant dose-dependent antinociception of ceftriaxone (25–200 mg/kg per day) was observed only after the 7-day pretreatment. Isobolographic analysis in the inflammatory hyperalgesia model revealed approximately 10-fold reduction of doses of both drugs in all examined combinations. In the visceral nociception model, more than 7- and 17-fold reduction of doses of both drugs was observed in combinations of ceftriaxone with ibuprofen/paracetamol and celecoxib/levetiracetam, respectively. Conclusions: Ceftriaxone exerts antihyperalgesia/antinociception in both somatic and visceral inflammatory pain. Its efficacy is higher after a 7-day pretreatment than after acute administration. The two-drug combinations of ceftriaxone and the nonsteroidal analgesics/levetiracetam have synergistic interactions in both pain models. These results suggest that ceftriaxone, particularly in combinations with ibuprofen, celecoxib, paracetamol, or levetiracetam, may provide useful approach to the clinical treatment of inflammation-related pain." @default.
• W2085594260 created "2016-06-24" @default.
• W2085594260 creator A5021839300 @default.
• W2085594260 creator A5034439466 @default.
• W2085594260 creator A5043666796 @default.
• W2085594260 creator A5072936762 @default.
• W2085594260 creator A5076714586 @default.
• W2085594260 date "2014-03-01" @default.
• W2085594260 modified "2023-10-18" @default.
• W2085594260 title "Antihyperalgesic/Antinociceptive Effects of Ceftriaxone and Its Synergistic Interactions with Different Analgesics in Inflammatory Pain in Rodents" @default.
• W2085594260 cites W1566146026 @default.
• W2085594260 cites W1963760749 @default.
• W2085594260 cites W1973640730 @default.
• W2085594260 cites W1988855593 @default.
• W2085594260 cites W1989516082 @default.
• W2085594260 cites W1989609722 @default.
• W2085594260 cites W1990550352 @default.
• W2085594260 cites W1991969184 @default.
• W2085594260 cites W1995506737 @default.
• W2085594260 cites W1996541880 @default.
• W2085594260 cites W2002063831 @default.
• W2085594260 cites W2005159022 @default.
• W2085594260 cites W2022497559 @default.
• W2085594260 cites W2022649353 @default.
• W2085594260 cites W2026181666 @default.
• W2085594260 cites W2034284267 @default.
• W2085594260 cites W2042999637 @default.
• W2085594260 cites W2049481868 @default.
• W2085594260 cites W2052310920 @default.
• W2085594260 cites W2059436946 @default.
• W2085594260 cites W2063190826 @default.
• W2085594260 cites W2068457260 @default.
• W2085594260 cites W2074866222 @default.
• W2085594260 cites W2075715972 @default.
• W2085594260 cites W2083204774 @default.
• W2085594260 cites W2089573540 @default.
• W2085594260 cites W2090389679 @default.
• W2085594260 cites W2094479806 @default.
• W2085594260 cites W2096184836 @default.
• W2085594260 cites W2105395808 @default.
• W2085594260 cites W2113011586 @default.
• W2085594260 cites W2114422424 @default.
• W2085594260 cites W2115412021 @default.
• W2085594260 cites W2121761530 @default.
• W2085594260 cites W2123258170 @default.
• W2085594260 cites W2124106811 @default.
• W2085594260 cites W2124353813 @default.
• W2085594260 cites W2128744963 @default.
• W2085594260 cites W2132889863 @default.
• W2085594260 cites W2133316133 @default.
• W2085594260 cites W2151203878 @default.
• W2085594260 cites W2151454520 @default.
• W2085594260 cites W2155433808 @default.
• W2085594260 cites W2158453961 @default.
• W2085594260 cites W2160779124 @default.
• W2085594260 cites W2327305614 @default.
• W2085594260 cites W2990007984 @default.
• W2085594260 doi "https://doi.org/10.1097/aln.0000435833.33515.ba" @default.
• W2085594260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24071615" @default.
• W2085594260 hasPublicationYear "2014" @default.
• W2085594260 type Work @default.
• W2085594260 sameAs 2085594260 @default.
• W2085594260 citedByCount "34" @default.
• W2085594260 countsByYear W20855942602014 @default.
• W2085594260 countsByYear W20855942602015 @default.
• W2085594260 countsByYear W20855942602016 @default.
• W2085594260 countsByYear W20855942602017 @default.
• W2085594260 countsByYear W20855942602018 @default.
• W2085594260 countsByYear W20855942602019 @default.
• W2085594260 countsByYear W20855942602020 @default.
• W2085594260 countsByYear W20855942602021 @default.
• W2085594260 countsByYear W20855942602022 @default.
• W2085594260 countsByYear W20855942602023 @default.
• W2085594260 crossrefType "journal-article" @default.
• W2085594260 hasAuthorship W2085594260A5021839300 @default.
• W2085594260 hasAuthorship W2085594260A5034439466 @default.
• W2085594260 hasAuthorship W2085594260A5043666796 @default.
• W2085594260 hasAuthorship W2085594260A5072936762 @default.
• W2085594260 hasAuthorship W2085594260A5076714586 @default.
• W2085594260 hasConcept C126322002 @default.
• W2085594260 hasConcept C15490471 @default.
• W2085594260 hasConcept C170493617 @default.
• W2085594260 hasConcept C2776467144 @default.
• W2085594260 hasConcept C2776520383 @default.
• W2085594260 hasConcept C2779794527 @default.
• W2085594260 hasConcept C42219234 @default.
• W2085594260 hasConcept C501593827 @default.
• W2085594260 hasConcept C71924100 @default.
• W2085594260 hasConcept C86803240 @default.
• W2085594260 hasConcept C89423630 @default.
• W2085594260 hasConcept C98274493 @default.
• W2085594260 hasConceptScore W2085594260C126322002 @default.
• W2085594260 hasConceptScore W2085594260C15490471 @default.
• W2085594260 hasConceptScore W2085594260C170493617 @default.
• W2085594260 hasConceptScore W2085594260C2776467144 @default.
• W2085594260 hasConceptScore W2085594260C2776520383 @default.
• W2085594260 hasConceptScore W2085594260C2779794527 @default.
• W2085594260 hasConceptScore W2085594260C42219234 @default.

• next